Marco Guazzi to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications Marco Guazzi has written about Phosphodiesterase 5 Inhibitors.
Connection Strength
0.263
-
Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation. Eur J Heart Fail. 2017 05; 19(5):691.
Score: 0.155
-
Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. PLoS One. 2011; 6(11):e27910.
Score: 0.108